Tech Company Financing Transactions

CG Oncology Funding Round

On 11/15/2022, CG Oncology raised $120 million in Series E funding from Decheng Capital, Longitude Capital Management and ORI Capital.

Transaction Overview

Company Name
CG Oncology
Announced On
11/15/2022
Transaction Type
Venture Equity
Amount
$120,000,000
Round
Series E
Investors

Decheng Capital (Lead Investor)

Longitude Capital Management (Lead Investor)

ORI Capital (Lead Investor)

Acorn Bioventures

Ally Bridge Group

Malin Corporation

RA Capital

Sirona Capital

Proceeds Purpose
The proceeds from the Series E financing will be used to advance the company's lead clinical programs in bladder cancer towards FDA approval as well as broaden the scope of its pipeline to address unmet medical needs in urologic cancer, such as the first-line setting in Bacillus Calmette-Guérin (BCG)-naïve, intermediate-risk non-muscle invasive bladder cancer (NMIBC) patients.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
400 Spectrum Center Dr. 2040
Irvine, CA 92618
USA
Phone
Undisclosed
Website
www.cgoncology.com
Email Address
[email protected]
Overview
Founded in 2010, CG Oncology is a privately-held, clinical-stage biopharmaceutical company focused on the research, acquisition and development of novel immunotherapies. CG Oncology is currently investigating the company's first product, CG0070, for the treatment of NMIBC in the BCG-unresponsive patient population.
Profile
CG Oncology LinkedIn Company Profile
Social Media
CG Oncology Company Twitter Account
Company News
CG Oncology News
Facebook
CG Oncology on Facebook
YouTube
CG Oncology on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Arthur Kuan
  Arthur Kuan LinkedIn Profile  Arthur Kuan Twitter Account  Arthur Kuan News  Arthur Kuan on Facebook
Chief Medical Officer
James Burke
  James Burke LinkedIn Profile  James Burke Twitter Account  James Burke News  James Burke on Facebook
Chief Scientific Officer
Paola Grandi
  Paola Grandi LinkedIn Profile  Paola Grandi Twitter Account  Paola Grandi News  Paola Grandi on Facebook
Chief Technical Officer
Georg Roth
  Georg Roth LinkedIn Profile  Georg Roth Twitter Account  Georg Roth News  Georg Roth on Facebook
Controller
Amy Steele
  Amy Steele LinkedIn Profile  Amy Steele Twitter Account  Amy Steele News  Amy Steele on Facebook
VP - Bus. Development
Bing Kung
  Bing Kung LinkedIn Profile  Bing Kung Twitter Account  Bing Kung News  Bing Kung on Facebook
VP - Operations
John McAdory
  John McAdory LinkedIn Profile  John McAdory Twitter Account  John McAdory News  John McAdory on Facebook
VP - Regulatory Affairs
Ursula Fritsch
  Ursula Fritsch LinkedIn Profile  Ursula Fritsch Twitter Account  Ursula Fritsch News  Ursula Fritsch on Facebook
VP - Regulatory Affairs
Jeffrey Ouano
  Jeffrey Ouano LinkedIn Profile  Jeffrey Ouano Twitter Account  Jeffrey Ouano News  Jeffrey Ouano on Facebook

 

 

Browse more venture capital transactions:

Prev: 11/15/2022: Pelico venture capital transaction
Next: 11/15/2022: Weka.IO venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

Our team works diligently to record tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.